Affordable Access

deepdyve-link
Publisher Website

Targeted Hypothermia vs Targeted Normothermia in Survivors of Cardiac Arrest: A Systematic Review and Meta-Analysis of Randomized Trials.

Authors
  • Elbadawi, Ayman1
  • Sedhom, Ramy2
  • Baig, Basarat3
  • Mahana, Ingy4
  • Thakker, Ravi5
  • Gad, Mohamed6
  • Eid, Mennallah7
  • Nair, Ajith1
  • Kayani, Waleed1
  • Denktas, Ali1
  • Elgendy, Islam Y8
  • Jneid, Hani9
  • 1 Section of Cardiology, Baylor College of Medicine, Houston, Texas.
  • 2 Department of Internal Medicine, Einstein Medical Center, Philadelphia, Penn.
  • 3 Department of Pulmonary and Critical Care Medicine, Brown University, Providence, RI.
  • 4 Department of Internal Medicine, Medstar Washington Hospital Center, Washington, DC.
  • 5 Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.
  • 6 Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio.
  • 7 Department of Internal Medicine, Lincoln Medical Center, New York, NY.
  • 8 Department of Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar. , (Qatar)
  • 9 Section of Cardiology, Baylor College of Medicine, Houston, Texas. Electronic address: [email protected]
Type
Published Article
Journal
The American journal of medicine
Publication Date
May 01, 2022
Volume
135
Issue
5
Identifiers
DOI: 10.1016/j.amjmed.2021.11.014
PMID: 34958763
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

The role of targeted hypothermia in patients with coma after cardiac arrest has been challenged in a recent randomized clinical trial. We performed a computerized search of MEDLINE, EMBASE, and Cochrane databases through July 2021 for randomized trials evaluating the outcomes of targeted hypothermia vs normothermia in patients with coma after cardiac arrest with shockable or non-shockable rhythm. The main study outcome was mortality at the longest reported follow-up. The final analysis included 8 randomized studies with a total of 2927 patients, with a weighted follow-up period of 4.9 months. The average targeted temperature in the hypothermia arm in the included trials varied from 31.7°C to 34°C. There was no difference in long-term mortality between the hypothermia and normothermia groups (56.2% vs 56.9%, risk ratio [RR] 0.96; 95% confidence interval [CI], 0.87-1.06). There was no significant difference between hypothermia and normothermia groups in rates of favorable neurological outcome (37.9% vs 34.2%, RR 1.31; 95% CI, 0.99-1.73), in-hospital mortality (RR 0.88; 95% CI, 0.77-1.01), bleeding, sepsis, or pneumonia. Ventricular arrhythmias were more common among the hypothermia vs normothermia groups (RR 1.36; 95% CI, 1.17-1.58; P = .42). Sensitivity analysis, excluding the Targeted Hypothermia vs Targeted Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, showed favorable neurological outcome with hypothermia vs normothermia (RR 1.45; 95% CI, 1.17-1.79). Targeted temperature management was not associated with improved survival or neurological outcomes compared with normothermia in comatose patients after cardiac arrest. Further studies are warranted to further clarify the value of targeted hypothermia compared with targeted normothermia. Published by Elsevier Inc.

Report this publication

Statistics

Seen <100 times